Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph phase_3
1
20%
Ph phase_1
2
40%
Ph phase_2
2
40%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Other(4)

Detailed Status

unknown4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)

Trials by Status

unknown480%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma

NCT06194656
unknownphase_3

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

NCT05751512
unknownphase_2

Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer

NCT03608046
unknownphase_1

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

NCT03491709
unknownphase_1

Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

NCT03881787

Clinical Trials (5)

Showing 5 of 5 trials
NCT06194656Phase 2

Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma

Recruiting
NCT05751512Phase 3

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Unknown
NCT03608046Phase 2

Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer

Unknown
NCT03491709Phase 1

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Unknown
NCT03881787Phase 1

Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

Unknown

All 5 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
5